Thank you. Good morning and good afternoon. Thank you for joining BioNtech's third quarter 2024earnings callAs a reminder, the slide that we will be using during this call and the corresponding press release we issued this morning can be found in the investor relations section of our website....
At the beginning of April 2022, BioNTech published its second ESG report (Sustainability Report 2021), which can be found in the Investor Relations section of BioNTech’s website. Upcoming Investor and Analyst Events The Annual General Meeting will take place on June 1, 2022. BioNTec...
Participants may also access the slides and the webcast of the conference call via the “Events & Presentations” page in the Investor Relations section of the Company’s website athttps://biontech.com/. A replay of the webcast will be made available shortly after the ...
CONTACTSPfizerMedia Relations +1 (212) 733-1226PfizerMediaRelations@pfizer.com Investor Relations +1 (212) 733-4848IR@pfizer.com BioNTechMedia Relations Jasmina Alatovic +49 (0)6131 9084 1513Media@biontech.de Investor RelationsVictoria Meissner, M.D.Investors@biontech.de --- 1U...
Investor Relations Michael Horowicz Investors@biontech.de Media Relations Jasmina Alatovic Media@biontech.de Interim Consolidated Statements of Profit or Loss (1)Adjustments to prior-year figures due to change in functional allocation of general and administrative expenses and other operating expenses. ...
Investor Relations +1 (212) 733-4848 IR@pfizer.com BioNTech: Media Relations Jasmina Alatovic +49 (0)6131 9084 1513 Media@biontech.de Investor Relations Victoria Meissner, M.D. +1 617 528 8293 Investors@biontech.de Source: Pfizer Inc. ...
Investor RelationsMichael Horowicz+1 617 955 7420Investors@biontech.de 生物科技公司投资者关系迈克尔·霍罗维奇+1 617 955 7420Investors@biontech.de Media RelationsJasmina Alatovic+49 (0)6131 9084 1513Media@biontech.de 媒体关系贾斯米娜·阿拉托维奇+49 (0) 6131 9084 1513Media@biontech.de OncoC4...
当被问及基于mRNA的癌症疫苗何时可以用于患者时，沙欣教授表示，可能是“2030年之前”。沙欣和图里奇夫妇...
For more information, please visitwww.dualitybiologics.com. CONTACTS BioNTech Investor Relations Michael Horowicz +1 617 955 7420 Investors@biontech.de Media Relations Jasmina Alatovic +49 (0)6131 9084 1513 Media@biontech.de DualityBio Business Development bd@dualitybiologics.com...
Investor Relations +1 (212) 733-4848IR@pfizer.com BioNTech: Media Relations Jasmina Alatovic +49 (0)6131 9084 1513Media@biontech.de Investor Relations Victoria Meissner, M.D. +1 617 528 8293Investors@biontech.de Source: Pfizer Inc. ...